As we are in the Holiday filled month of December, I wish everyone a moment to pause and reflect on how life has changed for each of us in the past 12 months.
As a Board, we have had many meetings, but all of them since 2020 have been virtual…..until this month when 21 PES members (8 from the Board) met to review and update the society’s strategic plan.
Many thanks to the 289 of you that completed the survey along with 17 phone interview participants. The consultant that worked with us on the review and revision of the plan analyzed all the data, and she made a point of saying that the comments numbered over 100 pages in total! That depth and breadth of feedback allows us, the Board, to make sure that we’re being responsive to your issues and needs and remain relevant. There were some insights that came from the data, both in terms of positive trends and areas of opportunity. The planning group are charged with getting this to next steps and we cannot do it alone. We will be sharing more detail of the reoccurring themes expressed as priorities and will be reaching out to our many volunteers on committees and SIGs to help flesh out the tactics/action items to help us realize the strategies identified in the goal areas that rose to the top.
You will hear more of the results of the Strategic Planning meeting in the coming months.
December is named the “tenth month” (Latin word, “decem,” means ten), because it was originally the 10th month of the year until January and February were granted entry to the Calendar Union.
December is unique as we have the shortest days, culminating with the Winter Solstice occurring on December 21. However, this is just for the Northern Hemisphere. In the Southern Hemisphere, such as in South America, it is on June 21, 2023. Speaking of South America, when the 11th International Meeting of Pediatric Endocrinology (IMPE) will take place in Buenos Aires (March 4-7, 2023), it will be the transition from Summer to Autumn.
In my next message, I will share some teasers of the PES Annual conference of May 5-8, 2023! Save the date and plan to join us.
I leave you with two cases, each where a specific observation led to a faster diagnosis.
Case A (from the 1990’s archive)
A 3-month-old girl was admitted with a fever and was having a sepsis work-up. When the physician obtained urine by catheterization, they noted an enlarged clitoris. The weekend endocrine fellow (JO) suggested to the ER staff, by telephone, to obtain a 17-hydroxy-progesterone, electrolytes, and while the results are pending, to administer stress dose steroids. No one in the family had CAH. The next day, the next fellow performed a consultation. He initially felt the chances of the girl having CAH to be low, until he asked the parents one particular question. What was that question? (Answer after the second case)
Case B
A 12-year-old boy was admitted for a water deprivation study. Apart from several months of marked polyuria and polydipsia, he was healthy. The referring endocrinologist felt DI was possible but not probable. On inpatient rounds, while examining this boy at the start of the water deprivation study, something was observed, and the diagnosis of DI went from possible to highly probable. What was that physical examination finding?
Answers:
In Case A, the parents were asked if there was consanguinity. Parents were first cousins. This significantly raised the chance of a recessive condition. The 17-OH progesterone returned approximately 20,000 ng/dL (630 nmol/L). This case pre-dated the Newborn Screen for CAH.
In Case B, the boy had a rash on his wrists and his groin. Dermatology was consulted and asked specifically if this was a rash suggestive of Langerhans Cell Histiocytosis (LCH). Dermatology was convinced it was indeed a rash of LCH and a biopsy provided confirmation. The water deprivation proved central DI, and the MRI showed an absent bright spot, and a thickened infundibulum but no bony lesions.
Sincerely.

Craig A. Alter, MD
News from the D&T Committee: Recent Backorders of Novo Flexpro Pens
NEW DSD Guidelines
The Department of Defense revised its regulations on medical qualification for military service, effective November 16th, 2022. The DSD-SIG and Board of PES supported efforts for revisions related to differences of sex development. Previously, many forms of DSD led to a blanket disqualification for service. This new standard disqualifies applicants with DSD if the DSD is “undiagnosed or untreated.” It allows for the treating provider to assess whether the condition has been treated to the extent medical necessary to avoid excessive loss of duty time or to interfere with performance. This appears to remove many barriers to to service for applicants with DSD conditions. Read more:
New Drugs and Therapeutics Update: TZIELDTM (teplizumab-mzwv)
The FDA recently approved TZIELDTM (teplizumab-mzwv), which is a CD-3 directed monoclonal antibody intended to delay the onset of stage 3 type 1 diabetes (T1D) in individuals 8 years and older with stage 2 T1D. Stage 2 T1D is defined as at least two positive pancreatic islet autoantibodies and dysglycemia, but not overt hyperglycemia, on an OGTT. Stage 2 T1D must be confirmed prior to initiating treatment with TZIELD. In a randomized, placebo-controlled, double-blind study of 76 participants with stage 2 T1D, teplizumab lengthened the median time to diagnosis of clinical diabetes from 27.1 months (placebo) to 59.6 months (hazard ratio, 0.457). Teplizumab is given as a once daily intravenous infusion for 14 days. Common adverse effects include lymphopenia and rash.
https://pedsendo.org/new-meds-and-tech/new-drugs-and-therapeutics-update-tzieldtm-teplizumab-mzwv/
Is it Time to Renew your Dues?
PES membership is on a calendar year so likely time to renew! Accessing your membership record and checking your membership status is easy!
- Visit the website and check your membership status by using your PES membership credentials and logging into this link: https://pedsendo.app.neoncrm.com/login.jsp
- Click the button in the top right corner labeled “Renew”. This will take you to the renewal page. Please also review your complete record and make sure the demographical information is filled out and current. This information helps us tailor program and services that best meet your needs and preferences.
For a receipt, click “Membership” on the left-hand side. Then select the membership charge you want a receipt for. Finally, click the “Download” button to download that receipt. Then you should be all set!
Calling All Fellows!
Career Pathways – Career Development Part 2
Date: January 20, 2023 / 3:00-5:00 PM ET
By the end of this activity, participants will be able to:
- Describe the career pathways available after endocrine fellowship
- Identify what career pathway/s match your skills, values and interests.
- Evaluate two possible career paths and next steps needed via networking with professionals at various stages of career in that track (clinician-scientist (basic/clinical), clinician-educator, industry, FDA, private practice)
Hormone Research in Paediatrics 2022, Vol. 95, No. 6
We are happy to announce that the December issue of HRP celebrating 50 years of the PES is now available on-line. Click here to view this exciting issue: https://pedsendo.us19.list-manage.com/track/click?u=c2f9ca8dede570897812773d0&id=dc908e1cf2&e=3130efeb26
You can also access this from the HRP link on the PES website. We thank the co-editors of this issue, Walter Miller, Alan Rogol, and our Immediate Past President, Sharon Oberfield on their efforts.
Do take a look at our history!!
Diabetes SIG: State of the Art Webinar
Join us on January 18 at 4:00 PM ET as we discuss setting up a clinic for type 2 diabetes youth.
Speakers: Megan Moriarty Kelsey, MD, MS, Claudia Retamal-Munoz, BSN, CDE (Diabetes Nurse Educator), Helen Seagle, RD (Dietitian), Lauren Gulley, PhD (Psychologist), Mayra Baca, PNP
EDI Spotlight: Notable January Events:
Equity, Diversity and Inclusion Initiative – Pediatric Endocrine Society (pedsendo.org)
Fellow Spotlight: Einas Alkhatib, MD
Meet Einas: December Fellow Spotlight – Einas Alkhatib, MD – Pediatric Endocrine Society (pedsendo.org)
Historical Tidbit: James Bertram Collip (20 November 1892 to 19 June 1965)
Submitted by Alan D. Rogol, MD, Ph.D: Historical Tidbit: James Bertram Collip (20 November 1892 to 19 June 1965) and Parathyroid Hormone – Pediatric Endocrine Society (pedsendo.org)